Our results demonstrate a new influence of PI3K on human T cell differentiation that is unrelated to its lipid-kinase activity and suggest that T<sub>FH</sub> should be monitored in APDS patients. The gene discussed is PIK3CD; the disease is activated PI3K-delta syndrome.